Antioxidant effects of potassium ascorbate with ribose therapy in a case with Prader Willi Syndrome

Disease Markers

Volumn 33, Issue 4, 2012, Pages 179-183

  Anichini, C ^a   Lotti, F ^a   Longini, M ^a   Proietti, F ^a   Felici, C ^a   Perrone, S ^a   Buonocore, G ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

isoprostanes; oxidative stress; potassium ascorbate with ribose; Prader Willi Syndrome

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ASCORBIC ACID; GROWTH HORMONE; HYDROPEROXIDE; ISOPROSTANE DERIVATIVE; POTASSIUM BICARBONATE; RIBOSE; THIOL;

ADOLESCENT; ANTIOXIDANT ACTIVITY; ARTICLE; CASE REPORT; CHROMOSOME 15; CHROMOSOME DELETION; FEMALE; HORMONE SUBSTITUTION; HUMAN; OXIDATIVE STRESS; PRADER WILLI SYNDROME; PRIORITY JOURNAL; WEIGHT REDUCTION;

IPS;

EID: 84872239730     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-0922     Document Type: Article

References (34)

1. Anichini C, Lo Rizzo C, Longini M, Paoli G, Di Bartolo RM, Proietti F, Buonocore G. beckwith-Wiedemann Syndrome: Potassium Ascorbate with Ribose Therapy in a Syndrome with High Neoplastic Risk. Anticancer Research. 2011 Nov; 31(11): 3973-6.
2. Aughton DJ, Cassidy SB. Physical features of Prader Willi syndrome. Am J Dis Child. 1990; 144: 1251-1254.
3. Beccaria L, Bosio L, Benzi F, Bregoni P, Achutegui I, Chiumello G, Livieri C, Trifir̀o G, De Toni T, Iughetti L, Ragusa L, Salvatoni A, Tonini G, Corrias A, Criǹo A. Prader Willi syndrome. Ann Ist Super Sanit̀a. 1999; 35(2): 221-232.
4. Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995; 378: 776-779.
5. Cassidy SB, Morris CA. Behavioral phenotypes in genetic syndromes: genetic clues to human behavior. Adv Pediatr. 2002; 49: 59-86.
6. Chobanyan J̈urgens K, Pham VV, Stichtenoth DO, Tsikas D. Asymmetrical Dimethylarginine, Oxidative Stress and Atherosclerosis. Hypertension. 2011 Nov; 58(5): e184-5.
7. Del Maestro R. An approach to free radicals in medicine and biology. Acta Physiol Scand. 1992; 492: 153-168.
8. FarooqiT, Farooqi AA. Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinson's Dis. 2011 Feb 15; 2011: 247467.
9. Groner Y, Elroy-Stein O, Avraham KB, Schickler M, Knobler H, Minc-Golomb D, Bar-Peled O, Yarom R, Rotshenker S. Cell damage by excess CuZnSOD and Down's syndrome. Biomed Pharmacother. 1994; 48: 231-240.
10. Halliwell B. Reactive oxygen species in living system: source, biochemistry and role in human disease. Am J Med. 1991; 91(3C): 14S-22S.
11. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet. 1994; 344: 721-724.
12. Hoffman C, Aultman D, Pipes P. A nutrition survey of and recommendations for individuals with Prader Willi syndrome who lives in group homes. J Am Diet Assoc. 1992; 92: 823-833.
13. Hu ML, Dillard CJ, Tappel AL. In vivo effects of aurothioglucose and sodium thioglucose on rat tissue sulfhydryl level and plasma sulfhydryl reactivity. Agents Action. 1988; 25: 132-138.
14. Kaneto H, Kawamori D, Matsuoka T. Oxidative stress and pancreatic beta-cell dysfunction. Am J Ther. 2005; 12: 529-533.
15. Kaplan J, Fredrickson PA, Richardson JW. Sleep and breathing in patients with the Prader Willi syndrome. Mayo Clin Proc. Nov 1991; 66(11): 1124-1126.
16. Knoll JH, Nicholls RD, Magenis RE, Graham JM, Lalande M, Latt SA. Angelman and Prader Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet. 1989; 32: 285-290.
17. Laurence B, Brito A,Wilkinson J. PraderWilli syndrome after 15 years. Arch Dis Child. 1981; 56: 181-186.
18. Ledbetter DH, Riccardi VM, Youngbloom SA, Strobel RJ, Keenan BS, Crawford JD. Deletions of chromosome 15 as a cause of the PraderWilli syndrome. N Engl J Med. 1981; 304: 325-329.
19. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005; 307: 384-387.
20. Mark JL. Oxygen free radicals linked to many diseases. Science. 1987; 235: 529-531.
21. Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-Isoprostanes as a biomarker of oxidative stress. Nature Protocol. 2007; 2(1): 221-226.
22. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader Willi syndrome. Nature. Nov 16 1989; 342(6247): 281-285.
23. Ozcelik T, Leff S, Robinson W. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader Willi syndrome critical region. Nature Genetics. 1992; 2: 265-269.
24. Paffetti P, Perrone S, Longini M, Ferrari A, Tanganelli D, Marzocchi B, Buonocore G. Non protein-bound iron detection in small samples of biological fluids and tissues. Biol Trace Elem Res. Sep 2006; 112(3): 221-232.
25. Perluigi M, Di Domenico F, Fiorini A, Cocciolo A, Giorgi A, Foppoli C, Butterfield DA, Giorlandino M, Giorlandino C, Schiniǹa ME, Coccia R. OS occurs early in Down syndrome pregnancy: a redox proteomics analysis of amniotic fluid. Proteomics Clin Appl. Apr 2011; 5(3-4): 167-178.
26. Perrone S, Longini M, Bellieni CV, Centini G, Kenanidis A, De Marco L, Petraglia F, Buonocore G. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem. Feb 2007; 40(3-4): 177-180.
27. Ragosta M. Rust in the pipes: the importance of oxidative stress in the pathophysiology of coronary artery disease and the valuable contribution of translational research. Atherosclerosis. 2011 Nov; 219(1): 26-7.
28. Saugstad OD. Oxygen toxicity in the neonatal period. Acta Paediatr Scand. 1990; 79: 881-892.
29. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr. 1996; 85: 1-4.
30. Schoeller D, Levitsky L, Bandini L, Dietz W,Walczak A. Energy expenditure and body composition in Prader Willi syndrome. Metabolism. 1988; 37: 115-120.
31. Stephenson JPB. Neonatal presentation of Prader Willi syndrome. Am J Dis Child. 1992; 146: 151-152.
32. Vals̀e Pantellini G. Breve cenno sulla genesi dei tumori e sopra una eventuale terapia dei medesimi con Sali di potassio e in particolare con ascorbato di potassio. Rivista di patologia clinica. 1970; 25(5): 219-225.
33. Warner BB, Wispe JR. Free radical-mediated diseases in pediatrics. Semin Perinatol. 1992; 16(1): 47-57.
34. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Thu Nguyen A, Zingraff J, Jungers P, Descamps-Latsca B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996; 49: 1304-1313.